Lowis & Gellen represented the sellers (“Sellers”) in the sale of their highly successful, Indiana based, medical device manufacturing business to a privately held company headquarted in California. This stock sale featured a substantial cash payment at closing, together with an escrowed holdback amount, an earn-out arrangement and a 338 election.
Click here to learn more about the business and its new owner.
The Lowis & Gellen team consisted of Gerald Haberkorn, Robert Leavitt, and Mehreen Sherwani, who assisted in the Sellers’ due diligence compliance and exclusively handled for the Sellers all legal aspects of the transaction including the structuring, drafting and negotiating of the sale, employment and non-competition documentation.
For more information, please contact:
Gerald Haberkorn, (312) 456-2701
geraldh@lowis-gellen.com
Tuesday, July 31, 2007
Subscribe to:
Posts (Atom)